Form 6-K ENERGY CO OF PARANA For: Dec 31

---

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

 

FORM 6-K

 

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

 

For the month of November, 2025

Commission File Number 1-14668

 

---

 

COMPANHIA PARANAENSE DE ENERGIA

(Exact name of registrant as specified in its charter)

 

Energy Company of Paraná

(Translation of Registrant's name into English)

 

José Izidoro Biazetto, 158
81200-240 Curitiba, Paraná
Federative Republic of Brazil
+55 (41) 3331-4011

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.  Form 20-F ___X___ Form 40-F _______

 Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____

 

 

 

COMPANHIA PARANAENSE DE ENERGIA - COPEL
CNPJ/ME 76.483.817/0001-20 - NIRE 41300036535 - CVM Registration 1431-1

B3 (CPLE3, CPLE5, CPLE6)

NYSE (ELP, ELPC)

LATIBEX (XCOP, XCOPO)

 

CHANGE IN THE EXECUTIVE BOARD OF COPEL GERAÇÃO E TRANSMISSÃO S.A.

 

Companhia Paranaense de Energia - Copel (“Copel” or the “Company”) hereby informs its shareholders and the market in general that, on this date, Mr. Fernando Mano da Silva has submitted his resignation from the position of General Director of Copel Geração e Transmissão (“Copel GeT”), for personal reasons and in full alignment with the Company’s Board of Directors, effective as of October 31, 2025.

As a result of the request, Mr. Moacir Carlos Bertol, Member of the Company's Board of Directors, will concurrently assume the position of General Director of Copel GeT.

Copel extends its appreciation to Mr. Fernando Mano for his contributions during his tenure.

The Company will keep its shareholders and the market informed of any developments regarding the subject matter of this Notice to the Market.

 

 

Curitiba, November 04, 2025

Felipe Guterres

Vice-President of Finance and Investor Relations

For further information, please contact the Investor Relations team:

[email protected] or (41) 3331-4011

 

 

 

SIGNATURE

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date November 4, 2025

 

COMPANHIA PARANAENSE DE ENERGIA – COPEL
By:	/S/  Daniel Pimentel Slaviero
	Daniel Pimentel Slaviero Chief Executive Officer

 

 

FORWARD-LOOKING STATEMENTS

 

This press release may contain forward-looking statements. These statements are statements that are not historical facts, and are based on management's current view and estimates of future economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.

---

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders
• Cornelis and xFusion Deliver High-Performance Infrastructure for European Automotive and Industrial HPC
• Aether AI Raises $20 Million Seed Round to Build Causal World Models for the Next Era of AI